Prevest Denpro Limited (BSE:543363) Q4 FY23 Earnings Concall dated May. 09, 2023. Corporate Participants: Atul Modi -- Chairman and Managing Director Namrata Modi -- Executive Director
Categories
Health Care
Poly Medicure Limited Q4FY23 Earnings
A medical equipment producer and exporter with its headquarters in India is called Poly Medicure Limited. The business exports surgical and medical
Windlas Biotech Limited (WINDLAS) Q4 FY23 Earnings Concall Transcript
Windlas Biotech Limited (NSE:WINDLAS) Q4 FY23 Earnings Concall dated May. 08, 2023. Corporate Participants: Hitesh Windlass -- Managing Director Komal Gupta -- Chief Executive Officer &
Alembic Pharmaceuticals Limited (APLLTD) Q4 FY23 Earnings Concall Transcript
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Raj Kumar Baheti -- Director, Finance & Chief Financial Officer
Tatva Chintan Pharma Chem Limited (TATVA) Q4 FY23 Earnings Concall Transcript
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Dinesh Sodani -- GM Finance Chintan Shah -- Managing Director
Ajanta Pharma Limited (AJANTPHARM) Q4 FY23 Earnings Concall Transcript
Ajanta Pharma Limited (NSE:AJANTPHARM) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Yogesh Agrawal -- Managing Director Rajesh Agrawal -- Joint Managing Director Arvind
VIMTA LABS LTD (VIMTALABS) Q4 FY23 Earnings Concall Transcript
VIMTA LABS LTD (NSE:VIMTALABS) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Vishal Manchanda -- Vice President, Institutional Research Narahari Naidu -- Chief Financial
Jyothy Laboratories Limited (JYOTHYLAB) Q4 FY23 Earnings Concall Transcript
Jyothy Laboratories Limited (NSE:JYOTHYLAB) Q4 FY23 Earnings Concall dated May. 03, 2023. Corporate Participants: Sanjay Agarwal -- Chief Financial Officer M R Jyothy -- Managing Director
Rossari Biotech Ltd (ROSSARI) Q4 FY23 Earnings Concall Transcript
Rossari Biotech Ltd (NSE:ROSSARI) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Aesha Shah -- Investor Relations Edward Menezes -- Executive Chairman & Co-Founder
Meghmani Organics Limited (MOL) Q4 FY23 Earnings Concall Transcript
Meghmani Organics Limited (NSE:MOL) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Ankit Patel -- Chief Executive Officer Gurjant Singh Chahal -- Chief Financial
RPG LIFE SCIENCES LTD (RPGL) Q4 FY23 Earnings Concall Transcript
RPG LIFE SCIENCES LTD (NSE:RPGL) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Yugal Sikri -- Managing Director Analysts: Sudarshan Padmanabhan -- JM Financial
Aarti Drugs Limited (AARTIDRUGS) Q4 FY23 Earnings Concall Transcript
Aarti Drugs Limited (NSE:AARTIDRUGS) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Adhish Patil -- Chief Financial Officer Harshit M. Savla -- Joint Managing
Glenmark Life Sciences Limited (GLS) Q4 FY23 Earnings Concall Transcript
Glenmark Life Sciences Limited (NSE:GLS) Q4 FY23 Earnings Concall dated Apr. 28, 2023. Corporate Participants: Soumi Rao -- General Manager, Corporate Communications Yasir Rawjee -- Managing
Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights
https://youtu.be/5Vtl-XMN8qg Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding non-ARV formulation
Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Transcript
Laurus Labs Limited (NSE:LAURUSLABS) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Satyanarayana Chava -- Founder & Chief Executive Officer V V
Dhampur Bio Organics Ltd (DBOL) Q4 FY23 Earnings Concall Transcript
Dhampur Bio Organics Ltd (NSE:DBOL) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Mr. Navin Agrawal -- Head of Institutional Equities Nalin
Syngene International Ltd (SYNGENE) Q4 FY23 Earnings Concall Transcript
Syngene International Ltd (NSE:SYNGENE) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Avantika Mishra -- Investor Relations Jonathan Hunt -- Managing Director and Chief
Laurus Labs Limited Q4FY23 Earnings
To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active Pharmaceutical Ingredients
Syngene reported 21 percent rise in its Q4FY23 net profit
Syngene reported Total revenue for Q4 FY23 of ₹994 Crore, up from ₹759 Crore year on year, a growth of 31%.While, consolidated
Syngene International Q4FY23 results out, revenue rises by 31%
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Nath Bio-Genes (India) Limited (NATHBIOGEN) Q4 FY23 Earnings Concall Transcript
Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Q4 FY23 Earnings Concall dated Apr. 24, 2023. Corporate Participants: Unidentified Speaker -- Devinder Khurana -- Chief Financial Officer Satish